These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 22306065

  • 1. Production and characterization of Clostridium perfringens recombinant β toxoid.
    Milach A, de los Santos JR, Turnes CG, Moreira AN, de Assis RA, Salvarani FM, Lobato FC, Conceição FR.
    Anaerobe; 2012 Jun; 18(3):363-5. PubMed ID: 22306065
    [Abstract] [Full Text] [Related]

  • 2. Potential protective immunogenicity of recombinant Clostridium perfringens α-β2-β1 fusion toxin in mice, sows and cows.
    Zeng J, Deng G, Wang J, Zhou J, Liu X, Xie Q, Wang Y.
    Vaccine; 2011 Jul 26; 29(33):5459-66. PubMed ID: 21641956
    [Abstract] [Full Text] [Related]

  • 3. Vaccination with recombinant Clostridium perfringens toxoids α and β promotes elevated antepartum and passive humoral immunity in swine.
    Salvarani FM, Conceição FR, Cunha CE, Moreira GM, Pires PS, Silva RO, Alves GG, Lobato FC.
    Vaccine; 2013 Aug 28; 31(38):4152-5. PubMed ID: 23845812
    [Abstract] [Full Text] [Related]

  • 4. Naturally occurring Clostridium perfringens nontoxic alpha-toxin variant as a potential vaccine candidate against alpha-toxin-associated diseases.
    Schoepe H, Pache C, Neubauer A, Potschka H, Schlapp T, Wieler LH, Baljer G.
    Infect Immun; 2001 Nov 28; 69(11):7194-6. PubMed ID: 11598102
    [Abstract] [Full Text] [Related]

  • 5. Induction of potential protective immunity against enterotoxemia in calves by single or multiple recombinant Clostridium perfringens toxoids.
    Jiang Z, De Y, Chang J, Wang F, Yu L.
    Microbiol Immunol; 2014 Nov 28; 58(11):621-7. PubMed ID: 25197030
    [Abstract] [Full Text] [Related]

  • 6. An EGFP-marked recombinant lactobacillus oral tetravalent vaccine constitutively expressing α, ε, β1, and β2 toxoids for Clostridium perfringens elicits effective anti-toxins protective immunity.
    Ding G, Bai J, Feng B, Wang L, Qiao X, Zhou H, Jiang Y, Cui W, Tang L, Li Y, Xu Y.
    Virulence; 2019 Dec 28; 10(1):754-767. PubMed ID: 31429624
    [Abstract] [Full Text] [Related]

  • 7. Clinicopathological and immunological studies on toxoids vaccine as a successful alternative in controlling clostridial infection in broilers.
    Saleh N, Fathalla SI, Nabil R, Mosaad AA.
    Anaerobe; 2011 Dec 28; 17(6):426-30. PubMed ID: 21664285
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Heterologous production and secretion of Clostridium perfringens beta-toxoid in closely related Gram-positive hosts.
    Nijland R, Lindner C, van Hartskamp M, Hamoen LW, Kuipers OP.
    J Biotechnol; 2007 Jan 10; 127(3):361-72. PubMed ID: 16959352
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Potency against enterotoxemia of a recombinant Clostridium perfringens type D epsilon toxoid in ruminants.
    Lobato FC, Lima CG, Assis RA, Pires PS, Silva RO, Salvarani FM, Carmo AO, Contigli C, Kalapothakis E.
    Vaccine; 2010 Aug 31; 28(38):6125-7. PubMed ID: 20670910
    [Abstract] [Full Text] [Related]

  • 12. Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.
    Rosskopf-Streicher U, Volkers P, Noeske K, Werner E.
    ALTEX; 2004 Aug 31; 21 Suppl 3():65-9. PubMed ID: 15057410
    [Abstract] [Full Text] [Related]

  • 13. Analysis of protection afforded by a Clostridium perfringens alpha-toxoid against heterologous clostridial phospholipases C.
    Neeson BN, Clark GC, Atkins HS, Lingard B, Titball RW.
    Microb Pathog; 2007 Oct 31; 43(4):161-5. PubMed ID: 17604945
    [Abstract] [Full Text] [Related]

  • 14. Immunogenicity of a Trivalent Recombinant Vaccine Against Clostridium perfringens Alpha, Beta, and Epsilon Toxins in Farm Ruminants.
    Moreira GM, Salvarani FM, da Cunha CE, Mendonça M, Moreira ÂN, Gonçalves LA, Pires PS, Lobato FC, Conceição FR.
    Sci Rep; 2016 Mar 23; 6():22816. PubMed ID: 27004612
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Orally administered recombinant Lactobacillus casei vector vaccine expressing β-toxoid of Clostridium perfringens that induced protective immunity responses.
    Alimolaei M, Golchin M, Ezatkhah M.
    Res Vet Sci; 2017 Dec 23; 115():332-339. PubMed ID: 28672254
    [Abstract] [Full Text] [Related]

  • 20. Enzyme linked immunosorbent assay for potency testing of vaccines containing Clostridium perfringens type D epsilon-toxoid.
    Pfahler W, Bisesti E, Pereyra JB, Iribarren F.
    Zentralbl Veterinarmed B; 1998 Apr 23; 45(3):133-9. PubMed ID: 9588107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.